The Industri Kapital 2000 Fund has completed its acquisition of CEVA Santé Animale (‘CEVA’) from PAI partners.
CEVA operates in the animal health industry which provides for the diagnosis, prevention, treatment of diseases and general well-being of livestock and companion animals. The company’s main expertise lies within the anti-infectives, vaccines and reproduction control devices areas.
CEVA operates in all key European Union markets and has a strong presence in international growing markets such as Eastern and Central Europe, Middle East and Turkey, Africa, Asia, and Latin America. In 2002, CEVA reported net sales of € 219 million. The company employs 1,200 people and is headquartered in Libourne, near Bordeaux (France).
For further information please contact:
Christopher Masek, Director, Industri Kapital, +44 20 7304 7127